Andrew I. Koven, President & Chief Business Officer at Aralez Pharmaceuticals Inc. (ARLZ), bought 20,000 shares at $2.55 ($51K) on 2017-03-15, disclosed to the SEC on 2017-03-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ARLZ | SELL | 2018-03-21 | $17K | — | Filing → |
| ARLZ | SELL | 2017-06-06 | $414K | — | Filing → |
| ARLZ | SELL | 2017-03-22 | $19K | — | Filing → |